Clinical Trial Update: Reflux Esophagitis Phase III Study (Initial Treatment) [Phase 3]

View source ↗

Summary

Phase III study (initial treatment) for reflux esophagitis completed, with trial results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Snippet

Sponsor: AstraZeneca | Conditions: Reflux Esophagitis | Phase 3 | Status: COMPLETED | Results posted: 2010-04-08